Primary Site >> Colorectal Cancer
Gene >> A2M
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group. PMID: 2871945 |
Ref: Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI). PMID: 3280478 |
Ref: The forms and the levels of fecal PMN-elastase in patients with colorectal diseases. PMID: 7872275 |
Ref: alpha2-Macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver. PMID: 8617438 |
Ref: Antioxidant status and proteolytic-antiproteolytic balance in colorectal cancer. PMID: 11820646 |
Ref: The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. PMID: 12670890 Ref: The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. PMID: 12782675 |
Ref: Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer. PMID: 19875126 |
Ref: An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer. PMID: 22395091 |
Ref: Lectin-based protein microarray analysis of differences in serum alpha-2-macroglobulin glycosylation between patients with colorectal cancer and persons without cancer. PMID: 26075587 |